Archive for the ‘Johnson & Johnson’ Tag

Johnson & Johnson Partnering with Smaller Drug Makers to Find Breakthroughs   Leave a comment

Johnson & Johnson is paying Pharmacyclics $50 million in what is called a milestone payment as the small drug researcher works on a new drug to combat mantel cell lymphoma, one of the more rare forms of NHL.

Apparently the drug giant is doing this thing more and more, as it allows the large company to benefit from innovation and advanced research without taking on the high risks that come with such work. It also, of course, gives funding to smaller companies in desperate need for the money. All in all, it sounds like a great plan to me.

The important thing of course, is that the research looks promising. Here’s hoping!

The two companies, which partnered up at the end of last year, are working to develop a novel kinase inhibitor known as ibrutinib as a medicine for patients who have suffered a relapse of mantel cell lymphoma, one of the rarest forms of non-Hodgkin’s lymphomas or cancers of the body’s B cells.

The drug candidate is also being studied as a treatment for patients who have developed a resistence to other medicines.

Pharmacyclics, which is based in Sunnyvale, Calif., said it is eligible to receive up to $725 million more in funding as it advances work on the drug.

Advertisements